Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 251 of 640

Advanced search

🇺🇰Aug 17Regulatorygov.ukTier 1 · Regulatory source

Tick-borne encephalitis: epidemiology, diagnosis and prevention

Advice for health professionals on tick-borne encephalitis (TBE) including symptoms, diagnosis and e...

UK Health Security AgencyOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

State Street SPDR S&P Biotech ETF (Derivatives): Latest News, Social Media Updates and Insights

CryptoRankOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

75th IPC to be held in New Delhi in December 2026

Express PharmaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

ExpreS2ion Biotech : to Host Q2 2026 Half-Year Report Presentation and Participate in Morgenbørs Live Podcast Interview

marketscreener.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

France Active Pharmaceutical Ingredients - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

New Delhi to Host 75th Indian Pharmaceutical Congress in December 2026 Focused on 2047 Industry Goals

geneonline.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Empowered Funds LLC Increases Stake in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Mumbai food safety sweep shuts famed restaurants

Kuwait TimesOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sandoz expands biosimilars business with Chinese biotech deal

swissinfo.chOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Dicot Pharma submits CTA for phase 2b study in EU

TradingViewOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

Italian biotech gains momentum as VC funding, tech transfer environment improve

BioSpaceOriginal source

🇯🇵Aug 17Devicesolympus-global.comTier 1 · Company source

Olympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System

Olympus MedicalOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Mesoblast Completes Treatment in Pivotal Phase 3 Back Pain Trial — Is This the Next Big Clinical Catalyst?

KalkineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Food Safety Crackdown Snares Mumbai's Famed Restaurants

ASHARQ AL-AWSAT EnglishOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Why has Maharashtra FDA issued notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff? | Explained

The HinduOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Bristol Myers Squibb opening pharmaceutical manufacturing campus near Houston

AOL.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sandoz to pay up to $77 mln for three biosimilar drug rights from Shanghai Henlius Biotech

Investing.com South AfricaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Why is Shanghai Henlius Biotech stock climbing today?

Investing.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Enhertu® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival as First-Line Treatment of Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial

Business WireOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical’s Epaminurad Shows Statistical Superiority in Phase III Gout Trial

BioPharma APACOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

Aizen strikes oral peptides deal with unnamed San Diego biotech

FirstWord PharmaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical : Continues to be Selected for ESG Investment Indexes Adopted by GPIF

marketscreener.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Resilient argenx stock backed by new Phase 3 success in autoimmune myositis

AD HOC NEWSOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Mesoblast (ASX:MSB) Shares up 9% Today, Phase 3 Low Back Pain Trial Reaches 350 Patients

KalkineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

2 ASX Healthcare Stocks That Gained Sharply Today: AGN and MSB in Focus

KalkineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down

Yahoo FinanceOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

PM Modi calls for Indian pharma companies to break into global top five

Indian Pharma PostOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Malls put eateries under scrutiny amid govt's hygiene crackdown

hospitality.economictimes.indiatimes.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Amgen stock holds steady as analyst lifts price target on obesity drug focus

AD HOC NEWSOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Argenica Therapeutics (ASX:AGN) Climbs on the ASX Gainers Board — But the Real Test for This Biotech Is Still Ahead

KalkineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Who is Tukaram Mundhe? Know the IAS Officer Leading Maharashtra’s FDA Crackdown

Adda247Original source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Comment: China’s biotech rise

Healthcare TodayOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

GlobeNewswireOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Jin Yongsheng from Jindu Biotech: Developing GeneLLM Multi-Omics Large Model to "Read" Raw Transcriptomic Signals From Zero to One – A New Starting Point for Biotech Innovation

36KrOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Shah Rukh Khan, Ajay Devgn, and Tiger Shroff under FDA scanner over Vimal advertisement

ET BrandEquityOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

FDA Commissioner and IAS officer Tukaram Mundhe’s 4 food safety tips for eating out: What every restaurant customer should check

The Times of IndiaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

(08/17/26) ABBV: A Promising Pharmaceutical Stock to Trade

moneyshow.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sun Pharma wins US Lipitor antitrust appeal, closing case

scanx.tradeOriginal source

🇺🇸Aug 17Regulatoryfda.govTier 1 · Regulatory source

Intraosseous Needle Set Recall: Becton Dickinson Removes Certain Intraosseous Vascular Access System Needle Sets

BD is recalling certain BD Intraosseous Vascular Access System Needle Sets due to difficulty removin...

FDA MedWatchOriginal source

🇺🇸Aug 17Industry4gclinical.comTier 1 · Company source

Biology Began Shaping the Trial - Science in Motion Series

4G ClinicalOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech

ReutersOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sandoz to Collaborate with Henlius Biotech on Up to 10 Biosimilars

marketscreener.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical clears Phase 3 gout trial, posts record quarterly earnings

헤럴드경제Original source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Turkey Active Pharmaceutical Ingredients - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Neuren Pharmaceuticals (ASX:NEU) Dips as Investors Monitor Commercial and Clinical Progress

KalkineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes (NDX)

Seeking AlphaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends Parle Agro license after expired drinks found in Mumbai warehouse

Kalinga TVOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

New once-weekly HIV treatment shows promise in clinical trials

IOLOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Genscript Biotech Widens Net Loss in H1

marketscreener.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Which ASX Small Caps Are Moving on Fresh Gold, Copper and Biotech News?

Kalkine MediaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: GenScript Biotech lifts H1 2026 profit on AIDD demand

Investing.com AustraliaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

manilatimes.netOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

SK bioscience Seeks South Africa Approval to Begin Phase 1b Trial of RSV Preventive Antibody RSM01

BioPharma APACOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Fauci’s Newly Released 2021 Texts Raise Pregnancy-Vaccine Questions—and FDA’s Current Comirnaty Label Shows Why the Debate Isn’t Over

trialsitenews.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

350 Patients Have Been Treated—Mesoblast’s Pain Data Come Next

Stock TitanOriginal source

🌍Aug 17Industryabelzeta.comTier 1 · Company source

AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma

AbelZeta PharmaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

[Weekend Money] Korean Biotech Aims for a Turnaround in the Second Half

아시아경제Original source

🇺🇸Aug 17Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source

🇯🇵Aug 17Industrysanten.comTier 1 · Company source

Santen Launches Rhopressa® Ophthalmic Solution 0.02% in Japan, a Treatment for Glaucoma and Ocular Hypertension

Santen PharmaceuticalOriginal source

🇺🇸Aug 17Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Request; 30-Day Public Comment Request; Submission for Office of Management and Budget Review; Generic Clearance for the Trusted Exchange Framework and Common Agreement (TEFCA) Monitoring Activities

The Office of the National Coordinator for Health IT (ONC), Office of the Secretary (OS), Department...

Federal RegisterOriginal source